News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
539,454 Results
Type
Article (13848)
Company Profile (188)
Press Release (525512)
Multimedia
Podcasts (95)
Webinars (16)
Section
Business (183676)
Career Advice (652)
Deals (28527)
Drug Delivery (46)
Drug Development (63176)
Employer Resources (78)
FDA (10745)
Job Trends (10068)
News (266610)
Policy (20663)
Tag
2027 BioCapital Standard (1)
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (4)
2027 Biotech Bay Standard (4)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (2)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (2)
Academia (676)
Accelerated approval (34)
ADA (24)
Adcomms (5)
Allergies (121)
Alliances (37364)
ALS (143)
Alzheimer's disease (1196)
Antibody-drug conjugate (ADC) (402)
Approvals (11364)
Artificial intelligence (485)
ASCO (221)
Autoimmune disease (254)
Automation (40)
Bankruptcy (279)
Best Places to Work (7727)
BIO (57)
BIOSECURE Act (16)
Biosimilars (181)
BioSpace Insights (68)
Biotechnology (118)
Bladder cancer (156)
Brain cancer (43)
Breast cancer (554)
Cancer (4462)
Cardiovascular disease (278)
Career advice (583)
Career pathing (40)
CAR-T (235)
CDC (15)
Celiac Disease (1)
Cell therapy (633)
Cervical cancer (39)
Clinical research (57075)
Collaboration (1620)
Commercialization (6)
Company closure (1)
Compensation (1586)
Complete response letters (59)
COVID-19 (1161)
CRISPR (71)
C-suite (1004)
Cystic fibrosis (101)
Data (6689)
Decentralized trials (1)
Denatured (18)
Depression (131)
Dermatology (70)
Diabetes (404)
Diagnostics (4461)
Digital health (43)
Diversity (7)
Diversity, equity & inclusion (19)
Drug discovery (223)
Drug pricing (67)
Drug shortages (5)
Duchenne muscular dystrophy (191)
Earnings (78837)
Editorial (51)
Employer branding (10)
Employer resources (69)
Events (97180)
Executive appointments (919)
FDA (13842)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (21)
Frontotemporal dementia (28)
Funding (1235)
Gene editing (148)
Generative AI (28)
Gene therapy (439)
GLP-1 (537)
Government (1511)
Grass and pollen (3)
Guidances (327)
Healthcare (10186)
Hematology (130)
HIV (62)
Huntington's disease (33)
IgA nephropathy (75)
Immunology and inflammation (177)
Immuno-oncology (90)
Indications (185)
Infectious disease (1392)
Inflammatory bowel disease (164)
Inflation Reduction Act (11)
Influenza (97)
Intellectual property (285)
Interviews (103)
IPO (13821)
IRA (19)
Job creations (2547)
Job search strategy (476)
JPM (36)
Kidney cancer (20)
Labor market (104)
Layoffs (249)
Leadership (39)
Legal (5543)
Licensing (8)
Liver cancer (63)
Longevity (17)
Lung cancer (671)
Lymphoma (318)
Machine learning (40)
Management (25)
Manufacturing (798)
Marketing (11)
MASH (181)
Medical device (8834)
Medtech (8977)
Mergers & acquisitions (15883)
Metabolic disorders (991)
mRNA (109)
Multiple sclerosis (147)
NASH (8)
Neurodegenerative disease (306)
Neuropsychiatric disorders (68)
Neuroscience (2338)
NextGen: Class of 2026 (3579)
Non-profit (995)
Now hiring (69)
Obesity (374)
Opinion (138)
Ovarian cancer (175)
Pain (197)
Pancreatic cancer (236)
Parkinson's disease (262)
Partnered (16)
Patents (538)
Patient recruitment (634)
Peanut (45)
People (46303)
Pharmaceutical (45)
Pharmacy benefit managers (10)
Phase 1 (18217)
Phase 2 (25641)
Phase 3 (17706)
Pipeline (8562)
Policy (167)
Postmarket research (1724)
Preclinical (7491)
Press Release (45)
Prostate cancer (227)
Psychedelics (28)
Radiopharmaceuticals (276)
Rare diseases (783)
Real estate (3659)
Recruiting (37)
Regulatory (17566)
Reports (49)
Research institute (763)
Resumes & cover letters (85)
Rett syndrome (41)
RNA editing (8)
RSV (56)
Schizophrenia (152)
Series A (214)
Series B (159)
Service/supplier (6)
Sickle cell disease (73)
Special edition (27)
Spinal muscular atrophy (101)
Sponsored (12)
Startups (2488)
State (1)
Stomach cancer (5)
Supply chain (70)
Tariffs (49)
The Weekly (76)
Vaccines (505)
Venture capital (81)
Weight loss (174)
Women's health (93)
Worklife (18)
Date
Today (67)
Last 7 days (449)
Last 30 days (1966)
Last 365 days (22946)
2026 (14698)
2025 (22857)
2024 (26719)
2023 (30799)
2022 (39014)
2021 (41863)
2020 (37478)
2019 (26804)
2018 (20212)
2017 (21959)
2016 (20836)
2015 (27086)
2014 (23806)
2013 (19766)
2012 (21565)
2011 (21802)
2010 (21552)
Location
Africa (355)
Alabama (88)
Alaska (2)
Arizona (324)
Arkansas (13)
Asia (26456)
Australia (3186)
California (12843)
Canada (3268)
China (1234)
Colorado (505)
Connecticut (481)
Delaware (328)
Europe (43157)
Florida (1914)
Georgia (389)
Hawaii (3)
Idaho (46)
Illinois (798)
India (74)
Indiana (397)
Iowa (19)
Japan (528)
Kansas (111)
Kentucky (32)
Louisiana (30)
Maine (27)
Maryland (1368)
Massachusetts (8827)
Michigan (315)
Minnesota (591)
Mississippi (5)
Missouri (89)
Montana (20)
Nebraska (13)
Nevada (115)
New Hampshire (67)
New Jersey (3079)
New Mexico (15)
New York (3248)
North Carolina (1509)
North Dakota (4)
Northern California (6487)
Ohio (302)
Oklahoma (18)
Oregon (27)
Pennsylvania (2397)
Puerto Rico (26)
Rhode Island (34)
South America (551)
South Carolina (77)
South Dakota (1)
Southern California (5251)
Tennessee (124)
Texas (2045)
United States (42809)
Utah (380)
Vermont (1)
Virginia (179)
Washington D.C. (49)
Washington State (1006)
West Virginia (2)
Wisconsin (86)
Wyoming (1)
539,454 Results for "akeso biopharma inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
China
Summit, Akeso’s China approval celebration cut short as survival benefit degrades
Ivonescimab notched its third approval in China last week, but the label update has tempered expectations for the Summit Therapeutics/Akeso drug, showing that progression-free survival declines over time.
August 17, 2026
·
2 min read
·
Annalee Armstrong
Immuno-oncology
ASCO: Akeso’s VEGF/PD-1 boosts lung cancer survival, relieving pressure on US partner Summit
Analysts, investors and partner Summit Therapeutics had all been keenly awaiting the overall survival update, after previous data from Akeso’s HARMONi-6 trial left them wanting.
May 31, 2026
·
3 min read
·
Annalee Armstrong
Lung cancer
Summit and Akeso sharpen case for ivonescimab with new Western data
Summit Therapeutics and Akeso are answering questions raised about ivonescimab’s ability to translate to Western populations, though the partners have yet to share if the new findings are statistically significant.
July 22, 2026
·
2 min read
·
Gabrielle Masson
China
Choosing China: Akeso’s $3M Beginnings and the Rise of China’s Biotech Sector
From a small team of researchers and skipped salaries, CEO Michelle Xia has steered Akeso to become one of the most exciting companies in the industry today.
September 17, 2025
·
8 min read
·
Tristan Manalac
Press Releases
Akeso Reports Full-Year 2025 Financial Results
March 27, 2026
·
10 min read
Press Releases
Akeso Doses First Patient in Phase II Study of Novel TROP2/Nectin-4 Bispecific ADC (AK146D1) in Combination with Ivonescimab for Advanced NSCLC
July 20, 2026
·
5 min read
Press Releases
Akeso Advances IO2.0 + ADC2.0 Strategy: First Patient Dosed in Phase II Study of TROP2/Nectin-4 Bispecific ADC (AK146D1) Combined with Ivonescimab in Breast Cancer
August 10, 2026
·
7 min read
Career Advice
The top 12 companies hiring in biopharma now
Looking for a biopharma job? Check out the
BioSpace
list of 12 top companies hiring life sciences professionals like you.
August 6, 2026
·
1 min read
·
Angela Gabriel
Podcast
ASCO wins from RevMed, Akeso/Summit, more; plus more Lilly and more China; ADA on deck
Improved survival on display at the American Society of Clinical Oncology (ASCO) in Chicago; Pfizer’s unusual pact with China’s Innovent highlights a new type of collaboration; Eli Lilly continues its nonstop deal streak, including with Chinese biotechs; and looking ahead to this weekend’s American Diabetes Association meeting.
June 3, 2026
·
2 min read
·
Jef Akst
Press Releases
Akeso’s Gumokimab (AK111, Anti-IL-17) Approved by NMPA for Moderate-to-Severe Plaque Psoriasis, Bolstering Its Autoimmune Disease Portfolio
June 12, 2026
·
6 min read
1 of 53,946
Next
